As part of a $10 million investment in 2024, new production lines for needles and syringes have been installed at BD’s plants in Connecticut and Nebraska, with one line already operational, according to a Jan. 15 news release from the company.
BD is also investing $30 million in 2025 to expand IV catheter production at its Utah facility, following a $2 million investment in 2024 that increased output by 40 million IV catheters per year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
